partly supported by the Molecular Imaging Program, a grant(21591561) from the Ministry of Education,Culture,Sports, Science,and Technology and the Japan Science and Technology Agency,Japan;the Research Promotion Program on Health from the National Institute of Biomedical Innovation,Japan;a Grant-in-Aid(H21-019 and H21-5) from the Ministry of Health, Welfare,and Labour,Japan
Paradoxical reduction of cerebral blood flow (CBF) after administration of the vasodilator acetazolamide is the most severe stage of cerebrovascular reactivity failure and is often associated with an increased oxyge...